2024 annual financial data
Tonix Pharmaceuticals Holding 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -603.58%.
Operating income was -136,701,000 USD and net income was -130,036,000 USD.
Operating cash flow was -60,925,000 USD.
Get free Tonix Pharmaceuticals Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,094,000 USD
- Operating income
- -136,701,000 USD
- Net income
- -130,036,000 USD
- Operating cash flow
- -60,925,000 USD